Intestinal Neuroendocrine Tumor — Trials

Intestinal Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00569127	Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor	active not recruiting	Phase 3	427	National Cancer Institute (NCI)NIH	1	Aug 28, 2026	clinicaltrials
NCT07759960	Underwater Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for the Treatment of Small Rectal Neuroendocrine Tumors	recruiting	N/A	174	Nanfang Hospital, Southern Medical UniversityOTHER	1	Aug 12, 2026	clinicaltrials
NCT06876532	Evaluation of the Inflammation-based Index as a Predictive Marker of Clinical and Radiological Response in Patients Treated With Lu-177 Oxodotreotide for Intestinal Neuroendocrine Tumour(LUTIBI)	recruiting	N/A	150	Institut Claudius RegaudOTHER	1	Jul 13, 2026

Data updated 22 days agoSource updated Aug 28, 2026source: clinicaltrials